Recommendations for the diagnosis and treatment of dense deposit disease

Nature Clinical Practice Nephrology

Volumn 4, Issue 2, 2008, Pages 68-69

  Andrésdóttir, Margrét B ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Dense deposit disease; Diagnosis; Membranoproliferative glomerulonephritis type II; Treatment

Indexed keywords

ECULIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRITIC FACTOR; RITUXIMAB; STEROID; SULODEXIDE;

DENSE DEPOSIT DISEASE; GENE MUTATION; GLOMERULUS BASEMENT MEMBRANE; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EDUCATION, MEDICAL, CONTINUING; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; ICELAND; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; PLASMA EXCHANGE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 38749091674     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0678     Document Type: Note

References (4)

1. Walker PD et al. (2007) Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol 20: 605-616
2. Appel GB et al. (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16: 1392-1403
3. Braun MC et al. (2005) Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol 16: 2225-2233
4. Lilford RJ et al. (1995) Clinical trials and rare diseases: a way out of a conundrum. BMJ 311: 1621-1625